Evidence map›Paper›PMID 35019685›Full record

ArticleMicrobiology spectrum2022

Assessment of Ceftazidime-Avibactam 30/20-μg Disk, Etest versus Broth Microdilution Results When Tested against

Renru Han, Xuelin Yang, Yang Yang, Yan Guo, Dandan Yin, Li Ding, Shi Wu, Demei Zhu, Fupin Hu

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Ceftazidime-avibactam activity againstIranian journal of microbiology · 2025
    Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Renru Han *Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Xuelin Yang *Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Yang YangInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Yan GuoInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Dandan YinInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Li DingInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Shi WuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Demei ZhuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.
Fupin HuInstitute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, China.ORCID 0000-0002-4493-0619
Fudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this research was to evaluate the correlation between inhibitory zones and MIC when testing ceftazidime-avibactam using disk diffusion, Etest, and broth microdilution method established by the Clinical and Laboratory Standards Institute (CLSI). Four-hundred and 58 isolates of

Indexed as

Anti-Bacterial AgentsAzabicyclo CompoundsCeftazidimeDisk Diffusion Antimicrobial TestsDrug CombinationsDrug Resistance, Multiple, BacterialEnterobacteriaceaeEnterobacteriaceae InfectionsHumansAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsCeftazidimeDrug Combinationsbroth microdilutionceftazidime-avibactamdisk diffusionEnterobacteralesEtest

Identifiers

PMID35019685
PMCPMC8865541
OpenAlexW4205390665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.